- About Us
- Pharmalicensing - Open Innovation for the life sciences
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Due Diligence
- Comparison
- Due Diligence
- Overview
- Top Applications
- Online Panel Discussions
- Request Consultation
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire
- Jobs
- Forums
- Contact Pharmalicensing
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
is a division of
Drug Development Summit
Summary
29 Apr 2009-30 Apr 2009 — London, UK
The Drug Development Summit 2009 will provide a first class educational and networking opportunity for over 200 attendees from leading pharmaceutical, biotechnology, diagnostics and clinical research companies as well as academic institutions in the UK, Europe and the US.
Contact details
Cerlin Roberts email: c.roberts@oxfordglobal.co.uk phone: +44 (0) 1865 811193
Venue
Radisson SAS
Summit — 29 Apr Wed-13:00 30 Apr 2009
The Inaugural Drug Development Summit 2009, presented by Oxford Global Conferences, will provide a first class educational and networking opportunity for over 200 attendees from leading pharmaceutical, biotechnology, diagnostics and clinical research companies as well as academic institutions in the UK, Europe and the US. It will take place on the 29th and 30th April 2009, in London UK.
Over two days the comprehensive scientific conference programme will feature keynote addresses, case study presentations, panel and roundtable discussions from over 45 speakers giving insight on how to effectively manage and streamline your Development process. Topics being covered at the Summit include:-
Safety Biomarkers & Toxicology: Looking at the elevated role of safety and toxicology, with case studies from multiple therapeutic areas
Screening and Enabling Technologies: Studying the role played by screening and enabling technologies in modernizing drug development
Partnership and Outsourcing Strategies in Drug Development: Implementing partnership and outsourcing strategies to strengthen core competencies with external expertise
Pharmacology/Pharmacogenomics/ADME: Best practices and optimization strategies in the study of predictive ADME, PK / PD - and how it
helps to achieve POC
Data Management & Clinical Operations: How to achieve operational excellence and efficiency in data handling and early clinical operations
Confirmed speakers at the event so far include:-
• Senior Vice President, Head of Discovery to Proof of Concept Development Organisation, Nycomed
• Executive Vice President and Chief Scientific Officer, Ceregene
• Vice President, Global Pharmacovigilance & Epidemiology - Medical Safety, Bristol-Myers Squibb
• Vice President Global Discovery Strategy and Performance, AstraZeneca
• Vice President & Global Head DSC, F. Hoffman-La Roche
• Vice President, Molecular Imaging, Clinical Pharmacology & Discovery Medicine, GlaxoSmithKline
• Vice President, Global Clinical & Medical Affairs, Baxter
• Global Head Data Management, Bayer-Schering Pharma
• Senior Director, Safety Surveillance and Risk Management, Wyeth Europa
• Senior Partnering Director, Teva Innovative Ventures, Teva Pharmaceutical Industries
• Director, Clinical Imaging Applications, GlaxoSmithKline
• Medical Science Director, AstraZeneca
• Director, Scientific Affairs, YM Biosciences
• Director, External Science Technology & Licensing, Bristol-Myers Squibb
• Study Director, Toxicology & Safety Pharmacology, Novartis Pharma
• Associate Director - Informatics Screening CoE Head, Pfizer
• Director, Late Clinical Development, Respiratory & Inflammation TA, AstraZeneca R&D
• Director, Clinical Operations, Santaris Pharma
• Director, Global Clinical Operations, MediGene AG
• Director, Toxicology, GSK Biologicals
• Worldwide Business Development Principal, Pfizer Ltd, UK
• Clinical Science Leader, F. Hoffman-La Roche
• Statistical Consultant, Basel, Switzerland
• Head of Early/Explanatory Toxicology, Merck KGaA
Early bird discounts are available by quoting "DEVDEL01". For information on sponsorship please email sponsorship@oxfordglobal.co.uk or call +44(0) 1865 811196. www.drugdevelopment-summit.com
© Copyright 1995-2009 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us